Navigation Links
DIFICID™ Demonstrated Early Superiority in the First 12 Days Compared to Vancomycin in New Analysis of Phase 3 Study Results
Date:10/20/2011

SAN DIEGO, Oct. 20, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) announced today that data being presented at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) demonstrate that patients treated with DIFICID™ (fidaxomicin) tablets for Clostridium difficile-associated diarrhea (CDAD) experienced faster resolution of diarrhea and lower risk of death during the first 12 days following initiation of treatment compared to patients treated with vancomycin. The retrospective analysis of results from two large, multi-national Phase 3 clinical studies, which assessed the efficacy of DIFICID versus vancomycin for the treatment of CDAD in adults, was completed by researchers from the National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford,  a research partnership between the Oxford Radcliffe Hospitals and the University of Oxford.

(Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

In the analysis, patients treated with DIFICID experienced a 37% reduction in persistent diarrhea or death through day 12 of the study (95% CI: 2-60%; p=0.037) compared to those treated with vancomycin. These data are among those featured in a late-breaking poster presentation at the IDSA annual meeting being held in Boston from October 20-23.

"We were encouraged by the results of the Phase 3 clinical studies and believed that a more comprehensive look at the patient characteristics of the Phase 3 study participants might yield even greater insights into the use of DIFICID for the treatment of CDAD," said Sarah Walker, PhD, Senior Statistician at the NIHR Biomedical Research Centre, Oxford, and the primary author of the analysis. "In our analysis, we found that DIFICID not only reduced persistent diarrhea and early death
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Optimer Pharmaceuticals and Astellas Receive Positive Opinion from CHMP for European Approval of DIFICID™
2. Optimer to Provide DIFICID™ Launch Update at Morgan Stanley Global Healthcare Conference
3. Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimers DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
4. Optimer Launches DIFICID™ (fidaxomicin) Tablets for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in Patients 18 Years of Age and Older
5. Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data
6. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
7. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
8. New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis
9. Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
10. Preclinical Studies in Pancreatic Cancer and Melanoma Demonstrated ADI-PEG 20 Works Synergistically With Inhibitors of Autophagy
11. Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Boehringer Ingelheim will contribute to ... the American Thoracic Society International Conference (ATS 2013) ... 17 – 22. Data will highlight ... treatment of chronic obstructive pulmonary disease (COPD) [Spiriva® ... investigational compounds for asthma, idiopathic pulmonary fibrosis (IPF) ...
(Date:5/17/2013)... PARIS , May 17, 2013  Sanofi (EURONEXT: ... the pivotal study, JAKARTA , examining ... its primary endpoint in both dose groups. The primary ... of spleen volume. Consistent with data reported in previous ... nausea and vomiting. Full results will be presented at ...
(Date:5/17/2013)... May 17, 2013  Boston Scientific Corporation (NYSE: ... annual EuroPCR Scientific Program May 21-24 in ... present a particularly rich and diversified set of data ... , M.D., global chief medical officer, Boston Scientific.  ... presented, including the NG PROMUS trial, which evaluated our ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8
... 2011 Giant Eagle®, the region,s leading food and ... prestigious Chairman,s Citation Award. Giant Eagle is ... the outstanding accomplishments of individuals, corporations, institutions and organizations ... had a positive impact in advancing the mission of ...
... new study conducted by the Institute for Alternative Futures ... Georgia, Pennsylvania, North Carolina and Michigan as "diabetes hot ... in the next 15 years.  " United States, Diabetes ... study to provide detailed diabetes prevalence and cost forecasts ...
Cached Medicine Technology:Giant Eagle® Receives American Diabetes Association Chairman's Citation Award 2Giant Eagle® Receives American Diabetes Association Chairman's Citation Award 3Ten States Bear Brunt of Diabetes Burden 2Ten States Bear Brunt of Diabetes Burden 3Ten States Bear Brunt of Diabetes Burden 4Ten States Bear Brunt of Diabetes Burden 5
(Date:5/20/2013)... BroadConnect Telecom, North America’s leading ... Security solution announced the release of its ... business customers with detailed advice for enhancing the ... With the latest solution sets, BroadConnect SMEs and ... some of the most commonly asked customer questions; ...
(Date:5/20/2013)... AlignLife of Waunakee is proud to announce that it ... children’s triathlon. Tri-4-Schools is a nonprofit organization that uses ... and fight childhood obesity. Their events aim to teach ... and self-confidence. Tri-4-Schools hopes to instill the basics of ... so they can make healthy choices that will benefit ...
(Date:5/20/2013)... 20, 2013 The Mesothelioma Victims ... US Navy Veterans who are diagnosed with mesothelioma get ... because they, or their family members turned to a ... one of the most skilled, and experienced mesothelioma lawyers ... of mesothelioma in the US never even bother to ...
(Date:5/20/2013)... Boulder, CO (PRWEB) May 20, 2013 ... scheduling calendar to their website package. This new ... package that allows clients to book appointments online. ... are engaging, professional, cost-effective, and extremely simple to ... their practice online. VetWebsites package (with no set-up ...
(Date:5/20/2013)... Healing Heart Urgent Care is pleased to ... Road in the Druid Hills neighborhood of Atlanta. ... E. De León M.D. and a group of licensed ... services, occupational health, chiropractic care and massage therapy for ... also offer a full range of physicals that may ...
Breaking Medicine News(10 mins):Health News:BroadConnect’s Latest Video Solution Sets Aimed at Providing Technical Insights for Businesses Hoping to Gain Greater Returns from their Investment in Communication and Security Solutions 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For The Names Of The Nation's Best Mesothelioma Lawyers-Better Compensation 3Health News:Veterinarians Can Now be on Vacation and Still Book Appointments with VetWebsites' New Calendar Feature 2Health News:Healing Heart Urgent Care Opens New Office In Atlanta 2
... 24, 2010 Feeling a little sluggish and having trouble ... from Concordia University published in the journal Brain and ... associated with an inability to pay attention and learn ... be due to a direct effect of the hormone on ...
... A new study looking at how hospitals account for ... infections (CA-BSIs) found substantial inconsistencies in the methods used ... infections. The study, conducted by the National ... Care Unit Focus Group, appears in the October issue ...
... HealthDay Reporter , THURSDAY, Sept. 23 (HealthDay News) -- ... flow to the brain, having a surgical procedure to widen ... British researchers report. The carotid artery -- one on ... to the head, so a procedure to widen it helps ...
... MD, chair of the Department of Pediatrics at the ... Physician-in-Chief at Rady Children,s Hospital-San Diego has received a ... Heart, Lung and Blood Institute. A world renowned ... collaborative team of investigators from UC San Diego and ...
... HealthDay Reporter , THURSDAY, Sept. 23 (HealthDay News) -- Distracted ... in the space of three years, according to new U.S. ... 16,000 deaths in car accidents from 2001 to 2007, the ... while driving rose 28 percent in just three years, from ...
... Mount Sinai School of Medicine have found that the costs ... were nearly five times higher than for patients who remained ... likely to use emergency department care and be hospitalized. ... the Journal of Clinical Oncology. Led by Melissa D.A. ...
Cached Medicine News:Health News:Can't focus? Maybe it's the wrong time of month 2Health News:Study of bloodstream infections reveals inconsistent surveillance methods and reporting 2Health News:Surgery to Widen Neck Arteries Cuts 10-Year Stroke Risk: Study 2Health News:Surgery to Widen Neck Arteries Cuts 10-Year Stroke Risk: Study 3Health News:Texting Taking a Deadly Toll on Roads 2Health News:Texting Taking a Deadly Toll on Roads 3Health News:Patients with cancer who stop hospice care boost health-care costs 2
Store microscope slides with ease, speed, efficiency....
... drawers for just about everything imaginable that might ... Each box is designed for long term storage ... of wood over metal systems is overlooked, while ... subtle kind of desiccator and insulator, providing an ...
A prepared Microscope Slide Cataloging and Storage System....
... resistant, plastic covered corrugated boxes interlock ... up to 500 lbs of overhead ... accommodates 2000 slides or 500 tissue ... requirements. Come unassembled boxes require minimal ...
Medicine Products: